Your browser doesn't support javascript.
loading
18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.
Jreige, Mario; Letovanec, Igor; Chaba, Kariman; Renaud, Stephanie; Rusakiewicz, Sylvie; Cristina, Valerie; Peters, Solange; Krueger, Thorsten; de Leval, Laurence; Kandalaft, Lana E; Nicod-Lalonde, Marie; Romero, Pedro; Prior, John O; Coukos, George; Schaefer, Niklaus.
Afiliación
  • Jreige M; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Letovanec I; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
  • Chaba K; Center of Experimental Therapies (CTE), Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Renaud S; Center of Experimental Therapies (CTE), Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Rusakiewicz S; Center of Experimental Therapies (CTE), Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Cristina V; Translational Tumor Immunology Group, Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.
  • Peters S; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Krueger T; Department of Thoracic Surgery, Lausanne University Hospital, Lausanne, Switzerland.
  • de Leval L; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
  • Kandalaft LE; Center of Experimental Therapies (CTE), Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Nicod-Lalonde M; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Romero P; Translational Tumor Immunology Group, Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.
  • Prior JO; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
  • Coukos G; Center of Experimental Therapies (CTE), Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Schaefer N; Translational Tumor Immunology Group, Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.
Eur J Nucl Med Mol Imaging ; 46(9): 1859-1868, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31214790
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Carcinoma de Pulmón de Células no Pequeñas / Fluorodesoxiglucosa F18 / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Carcinoma de Pulmón de Células no Pequeñas / Fluorodesoxiglucosa F18 / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2019 Tipo del documento: Article País de afiliación: Suiza